Avanos Medical (AVNS) Net Margin (2013 - 2026)

Avanos Medical has disclosed Net Margin across 12 years of filings, most recently posting 2.8% for Q1 2026.

• Net Margin for Q1 2026 came in at 2.8%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.71% (up 135.0% YoY), and the FY2024 annual result was 0.84%, up 687.0% from the prior year.
• Net Margin came in at 2.8% for Q1 2026 at Avanos Medical, up from 0.17% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 4.58% in Q1 2023 to a low of 37.66% in Q2 2023.
• The 4-year median for Net Margin is 2.73% (2022), against an average of 1.31%.
• Across the five-year window, Net Margin surged 7575 bps in 2022 and plunged 4217 bps in 2023, its largest moves.
• Avanos Medical's Net Margin stood at 3.96% in 2022, then plunged by 107 bps to 0.29% in 2023, then jumped by 42 bps to 0.17% in 2024, then soared by 1776 bps to 2.8% in 2026.
• The last three Net Margin figures came in at 2.8% (Q1 2026), 0.17% (Q4 2024), and 0.94% (Q3 2024), per Business Quant data.